Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.44 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.39 |
| ▸ | ECE1 | P42892 | 4/20 | 0.37 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4260374 | 1.00 | PTGS1 (0.44) | PTGS1GSTK1GLO1ECE1PDCD1LG2 | |
| SCHEMBL8045766 | 1.00 | PTGS1 (0.44) | PTGS1GSTK1GLO1ECE1PDCD1LG2 | |
| SCHEMBL10622634 | 0.99 | PTGS1 (0.43) | PTGS1GSTK1GLO1ECE1PDCD1LG2 | |
| SCHEMBL6831118 | 0.99 | PTGS1 (0.43) | PTGS1GSTK1GLO1ECE1PDCD1LG2 | |
| SCHEMBL8716377 | 0.99 | PTGS1 (0.43) | PTGS1GSTK1GLO1ECE1PDCD1LG2 | |
| SCHEMBL8135287 | 0.97 | PTGS1 (0.45) | PTGS1GSTK1GLO1ECE1 | |
| SCHEMBL8431345 | 0.97 | PTGS1 (0.45) | PTGS1GSTK1GLO1ECE1 | |
| SCHEMBL9225749 | 0.96 | PTGS1 (0.44) | PTGS1GSTK1GLO1ECE1CTSD | |
| SCHEMBL901171 | 0.94 | PTGS1 (0.47) | PTGS1GSTK1GLO1ECE1PDCD1LG2 | |
| SCHEMBL247775 | 0.94 | PTGS1 (0.44) | PTGS1GSTK1GLO1ECE1PDCD1LG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019004878-A1 | PREPARATION OF WHEAT CYSTEINE PROTEASE TRITICAIN-ALPHA PRODUCED IN SOLUBLE FORM AND METHOD OF PRODUCING SAME | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | 2019-01-03 | — | — | WO | claimed |
| CN-101646690-B | anti-IL-17A antibodies | SCHERING CORP | 2013-10-23 | — | — | CN | claimed |
| US-6433148-B1 | IMMUNOGLOBULIN ANTIBODIES WITH AMINO ACID SEQUENCES | CENTRO DE IMMUNOLOGIA MOLECULAR (CIM) (CU) | 2002-08-13 | — | — | US | claimed |
| WO-2002020840-A1 | ANTISENSE MODULATION OF UBIQUITIN PROTEIN LIGASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-14 | — | — | WO | claimed |
| CN-1175958-A | Monoclonal anti-idiotypic antibodies (AB2) and uses thereof | INMUNOLOGIA MOLECULAR CIM CENT (CU) | 1998-03-11 | — | — | CN | claimed |
| EP-0820472-A1 | MONOCLONAL ANTIIDIOTYPIC ANTIBODIES (AB2) AND USES THEREOF | Centro de Inmunologia Molecular (CU) | 1998-01-28 | — | — | EP | claimed |
| WO-1997019113-A2 | MONOCLONAL ANTIIDIOTYPIC ANTIBODIES (AB2) AND USES THEREOF | CENTRO DE INMUNOLOGIA MOLECULAR (CIM) (CU) | 1997-05-29 | — | — | WO | claimed |
| WO-2025042953-A1 | ANTIBODY-DRUG COMPLEXES WITH TOPOISOMERASE INHIBITORS | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-02-27 | — | — | WO | disclosed |
| CN-114246953-B | Anti-cMet antibody drug conjugates and methods of use thereof | 艾伯维生物制药股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-114177308-B | Anti-cMet antibody drug conjugates and methods of use thereof | 艾伯维生物制药股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-12031157-B2 | Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy | IOVANCE BIOTHERAPEUTICS, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| CN-112955463-B | Anti-CXCR 2 antibodies and uses thereof | 赛福伦有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-113862326-B | Application of KREMEN1 and/or ASGR1 as drug target in treating SARS-CoV-2 infection | 复旦大学 | 2024-07-05 | — | — | CN | disclosed |
| EP-0585396-A1 | NOVEL $i(BACILLUS THURINGIENSIS) ISOLATES ACTIVE AGAINST HYMENOPTERAN PESTS AND GENES ENCODING HYMENOPTERAN-ACTIVE TOXINS | MYCOGEN CORPORATION (US) | 1994-03-09 | — | — | EP | disclosed |
| EP-0584232-A1 | NOVEL -i(BACILLUS THURINGIENSIS) ISOLATES FOR CONTROLLING ACARIDES. | MYCOGEN CORP (US) | 1994-03-02 | — | — | EP | disclosed |
| WO-1994001553-A1 | RECEPTOR DERIVATES WITH BINDING SITES FOR HUMAN RHINOVIRUSES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 1994-01-20 | — | — | WO | disclosed |
| WO-1993003162-A1 | ECDYSTEROID DEPENDENT REGULATION OF GENES IN MAMMALIAN CELLS | GENENTECH, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
| WO-1992020802-A2 | NOVEL BACILLUS THURINGIENSIS ISOLATES ACTIVE AGAINST HYMENOPTERAN PESTS AND GENES ENCODING HYMENOPTERAN-ACTIVE TOXINS | MYCOGEN CORPORATION (US) | 1992-11-26 | — | — | WO | disclosed |
| WO-1992019739-A1 | NOVEL NEMATODE-ACTIVE TOXINS AND GENES WHICH CODE THEREFOR | MYCOGEN CORPORATION (US) | 1992-11-12 | — | — | WO | disclosed |
| WO-1992019106-A1 | NOVEL BACILLUS THURINGIENSIS ISOLATES FOR CONTROLLING ACARIDES | MYCOGEN CORPORATION (US) | 1992-11-12 | — | — | WO | disclosed |